共 97 条
[1]
Targownik LE(2014)Risk factors and management of osteoporosis in inflammatory bowel disease Curr Opin Gastroenterol 30 168-174
[2]
Bernstein CN(2005)Clinical practice. Screening for osteoporosis N Engl J Med 353 164-171
[3]
Leslie WD(2009)Survey of gastroenterologists’ awareness and implementation of AGA guidelines on osteoporosis in inflammatory bowel disease patients: are the guidelines being used and what are the barriers to their use? Inflamm Bowel Dis 15 1082-1089
[4]
Raisz LG(2011)Prescription drug use in IBD: a population based study Gastroenterology 140 S778-S779
[5]
Wagnon JH(2016)Corticosteroid use in a prospective, community-based cohort of newly diagnosed inflammatory bowel disease patients Dig Dis Sci 61 1635-1640
[6]
Leiman DA(2013)Opportunistic screening for osteoporosis using abdominal computed tomography scans obtained for other indications Ann Intern Med 158 588-595
[7]
Ayers GD(2005)Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology Can J Gastroenterol 19 5A-36A
[8]
Schwartz DA(2013)Utilization of preventive measures for glucocorticoid-induced osteoporosis among veterans with inflammatory bowel disease ISRN Gastroenterol 2013 862312-1361
[9]
Targownik LE(2005)Are patients with inflammatory bowel disease receiving optimal care? Am J Gastroenterol 100 1357-1550
[10]
Singh H(2006)Do guidelines matter? Implementation of the ACG and AGA osteoporosis screening guidelines in inflammatory bowel disease (IBD) patients who meet the guidelines’ criteria Am J Gastroenterol 101 1546-408